Saba Capital Sells $388,735 Stake in BlackRock ECAT Trust

Key Facts

1Saba Capital Management sold 26,644 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) for approximately $388,735.

2The transaction took place on September 14, 2026, with shares priced at $14.59 each.

3Saba Capital still beneficially owns over 12.7 million shares of ECAT following the sale.

In a move reflecting strategic adjustments by major institutional holders, Saba Capital Management has reduced its position in the BlackRock ESG Capital Allocation Term Trust (ECAT). According to reports, the firm sold approximately 26,644 shares for a total value of $388,735. The transaction was executed on September 14, 2026, at a price of $14.59 per share.

The sale follows the trust's recent announcement of a rights offering and occurs while the stock trades near its 52-week low despite maintaining a high dividend yield. Despite this reduction, Saba Capital remains a significant stakeholder, beneficially owning over 12.7 million shares of ECAT following the transaction. Per market data, shares of the parent company BlackRock (BLK) stood at $1065.6 at the close of September 14, 2026.

Traders should watch for further price stabilization in ECAT shares following this insider activity, particularly given the current valuation levels. Based on the economic calendar, there are no high-impact catalysts scheduled for the trust in the coming week; however, the broader performance of BlackRock (BLK), which saw a day low of $1057.72 on September 14, 2026, remains a key indicator for sector sentiment.